Impact of antifungal treatment on Candida–Pseudomonas interaction: a preliminary retrospective case–control study
暂无分享,去创建一个
R. Favory | S. Nseir | B. Cavestri | C. di Pompéo | E. Jozefowicz | A. Durocher | B. Sendid | F. Dewavrin | M. Roussel-Delvallez
[1] J. Garnacho-Montero,et al. A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization* , 2006, Critical care medicine.
[2] T. Fabian,et al. Candida sp. isolated from bronchoalveolar lavage: clinical significance in critically ill trauma patients , 2006, Intensive Care Medicine.
[3] C. Cracco,et al. Bonne pratique de la fibroscopie bronchique chez le patient ventilé , 2006 .
[4] Sanjay Saint,et al. Clinical and economic consequences of ventilator-associated pneumonia: A systematic review , 2005, Critical care medicine.
[5] A. Prince,et al. Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. , 2005, American journal of respiratory and critical care medicine.
[6] R. Piarroux,et al. Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients(*) , 2004, Critical care medicine.
[7] R. Kolter,et al. A Pseudomonas aeruginosa quorum‐sensing molecule influences Candida albicans morphology , 2004, Molecular microbiology.
[8] S. Kohno,et al. Acute infection with influenza virus enhances susceptibility to fatal pneumonia following Streptococcus pneumoniae infection in mice with chronic pulmonary colonization with Pseudomonas aeruginosa , 2004, Clinical and experimental immunology.
[9] J. Timsit,et al. Practices in non-neutropenic ICU patients with Candida-positive airway specimens , 2004, Intensive Care Medicine.
[10] C. Celum. The interaction between herpes simplex virus and human immunodeficiency virus. , 2004, Herpes : the journal of the IHMF.
[11] C. Marquette,et al. Diagnosis of hospital-acquired pneumonia: postmortem studies. , 2003, Infectious disease clinics of North America.
[12] D. Pittet,et al. Management of candidiasis Management of Candida species infections in critically ill patients , 2003 .
[13] R. Kolter,et al. Pseudomonas-Candida Interactions: An Ecological Role for Virulence Factors , 2002, Science.
[14] D. Maki,et al. The Commonality of Risk Factors for Nosocomial Colonization and Infection with Antimicrobial-Resistant Staphylococcus aureus, Enterococcus, Gram-Negative Bacilli, Clostridium difficile, and Candida , 2002, Annals of Internal Medicine.
[15] C. Heyer,et al. Biofilm formation in endotracheal tubes. Association between pneumonia and the persistence of pathogens. , 2002, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.
[16] Jean-Yves Fagon,et al. Ventilator-associated pneumonia. , 2002, American journal of respiratory and critical care medicine.
[17] David S. Jones,et al. Implications of endotracheal tube biofilm for ventilator-associated pneumonia , 1999, Intensive Care Medicine.
[18] E. Phizicky,et al. A functional homolog of a yeast tRNA splicing enzyme is conserved in higher eukaryotes and in Escherichia coli. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[19] E. Law,et al. Increased susceptibility to lethal Candida infections in burned mice preinfected with Pseudomonas aeruginosa or pretreated with proteolytic enzymes , 1986, Infection and immunity.
[20] J. Timsit,et al. Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia. , 2006, Chest.
[21] D. Pittet,et al. Management of Candida species infections in critically ill patients. , 2003, The Lancet. Infectious diseases.